Church & Dwight vs Stepan
CHD and SCL side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CHD and SCL compare
Church & Dwight is the larger company, worth 16 times as much as Stepan ($25.4B against $1.6B).
Stepan grew revenue faster over the last twelve months (7.6% versus 1.7% for Church & Dwight).
Church & Dwight keeps more of each dollar of sales as profit, with a net margin of 12.4% compared with −0.11% at Stepan.
Both pay dividends: Church & Dwight yields 1.1% and Stepan 2.3%.
Church & Dwight scores higher on the StockData Score (17 against 6 for Stepan), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHD | SCL |
|---|---|---|
| Size and price | ||
| Market cap | $25.4B | $1.6B |
| Share price | $107.23 | $69.61 |
| Change, 1 year | 31.0% | 57.6% |
| Change, 5 years | 20.8% | −45.8% |
| Beta (5Y) | 0.31 | 0.89 |
| Employees | 5,550 | – |
| StockData Score | ||
| Total score | 17 (better) | 6 |
| Valuation score | 1 | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 4 (better) | 2 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 33.0× | – |
| P/S | 4.1× | 0.7× (better) |
| P/B | 5.7× | 1.3× (better) |
| EV/EBITDA | 24.2× | 14.2× (better) |
| P/FCF | 24.0× (better) | 43.3× |
| PEG | 1.53 | – |
| FCF yield | 4.2% (better) | 2.3% |
| Fair value | $85.55 | $65.93 |
| Margin of safety | −25.3% | −5.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.7% | 7.6% (better) |
| Revenue growth, 5Y average | 4.8% (better) | 4.5% |
| Net income growth (TTM) | −0.98% (better) | −105% |
| EPS growth (TTM) | 2.2% (better) | −105% |
| EPS growth, 5Y average | −0.65% (better) | −17.8% |
| Profitability | ||
| Gross margin | 46.1% (better) | 11.8% |
| Operating margin | 18.0% (better) | 0.82% |
| Net margin | 12.4% (better) | −0.11% |
| FCF margin | 16.9% (better) | 1.5% |
| Return on equity | 17.8% (better) | −0.22% |
| Return on invested capital | 14.3% (better) | 0.88% |
| Financial health | ||
| Debt / equity | 0.49 (better) | 0.53 |
| Net debt / EBITDA | 1.56 (better) | 3.58 |
| Interest coverage | 11.6× | – |
| Current ratio | 0.96 | 1.15 (better) |
| Altman Z-score | 5.28 (better) | 2.64 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | 2.3% (better) |
| Payout ratio | 37.5% | – |
| Years of dividend growth | 16 | 16 |
| Dividend growth, 5Y average | 4.2% | 6.5% (better) |
| Shareholder yield | 1.1% | 2.3% (better) |
| Ownership | ||
| Held by institutions | 92.3% | 87.6% |
| Held by insiders | 0.12% | 4.7% |
| Insider net buying, 12 months | −$12.1M | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.1% | 3.1% |
Go deeper
- CHD stock overview
- CHD income statement
- CHD valuation and score
- SCL stock overview
- SCL income statement
- SCL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.